Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Sell
46
DCTH Quote, Financials, Valuation and Earnings
Last price:
$11.36
Seasonality move
:
-5.88%
Day range:
$11.13 - $11.59
52-week range:
$3.70 - $13.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
13.59x
P/B ratio:
42.30x
Volume:
113.3K
Avg. volume:
398K
1-year change:
182.79%
Market cap:
$362.6M
Revenue:
$2.1M
EPS (TTM):
-$1.20
Analysts' Opinion
-
Consensus RatingDelcath Systems has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Delcath Systems has an estimated upside of 88.13% from its current price of $11.34.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $11.34.
Fair Value
-
According to the consensus of 0 analysts, Delcath Systems has 88.13% upside to fair value with a price target of -- per share.
DCTH vs. S&P 500
-
Over the past 5 trading days, Delcath Systems has underperformed the S&P 500 by -7.75% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Delcath Systems does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Delcath Systems has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Delcath Systems reported revenues of $11.2M.
Earnings Growth
-
Delcath Systems has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Delcath Systems reported earnings per share of $0.06.
Enterprise value:
350.6M
EV / Invested capital:
33.17x
Price / LTM sales:
13.59x
EV / EBIT:
--
EV / Revenue:
15.48x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-13.38x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$18.4M
Return On Assets:
-90.81%
Net Income Margin (TTM):
-150.7%
Return On Equity:
-251.36%
Return On Invested Capital:
-167.55%
Operating Margin:
-11.24%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $4.2M | $2.2M | $22.6M | $434K | $11.2M | |
| Gross Profit | $3.6M | $1.5M | $18.4M | $301K | $9.6M | |
| Operating Income | -$30.7M | -$34.7M | -$26.8M | -$10.6M | -$1.3M | |
| EBITDA | -$30.5M | -$42.5M | -$36.8M | -$19.7M | -$1.2M | |
| Diluted EPS | -$3.99 | -$3.33 | -$1.20 | -$1.14 | $0.06 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $13.9M | $32.3M | $18.5M | $46.1M | $28.9M | |
| Total Assets | $16.6M | $34.4M | $20.2M | $47.6M | $31.7M | |
| Current Liabilities | $10.6M | $5.4M | $14.4M | $14M | $21.6M | |
| Total Liabilities | $13.3M | $22.7M | $25.5M | $22.9M | $23.1M | |
| Total Equity | $3.3M | $11.7M | -$5.2M | $24.7M | $8.6M | |
| Total Debt | $2M | $15.4M | $16.2M | $10M | $2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$23.6M | -$30.4M | -$25.9M | -$9.2M | -$3.6M | |
| Cash From Investing | -$208K | -$39K | -$5.4M | $1K | -$697K | |
| Cash From Financing | $8.8M | $57M | -$974K | $35.1M | -$2.1M | |
| Free Cash Flow | -$23.8M | -$30.5M | -$26.2M | -$9.2M | -$3.9M | |
DCTH
Sector
Market Cap
$362.6M
$46.1M
Price % of 52-Week High
85.26%
46.02%
Dividend Yield
0%
0%
Shareholder Yield
-2.11%
-0.6%
1-Year Price Total Return
182.79%
-30.52%
Beta (5-Year)
0.851
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$11.53
200-day SMA
Buy
Level
$8.16
Bollinger Bands (100)
Buy
Level
8.48 - 11.2
Chaikin Money Flow
Sell
Level
-1.3B
20-day SMA
Sell
Level
$11.63
Relative Strength Index (RSI14)
Buy
Level
51.29
ADX Line
Buy
Level
11.58
Williams %R
Neutral
Level
-76.8727
50-day SMA
Buy
Level
$10.81
MACD (12, 26)
Buy
Level
0.21
25-day Aroon Oscillator
Buy
Level
60
On Balance Volume
Sell
Level
-202M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-19.0825)
Sell
CA Score
(Annual)
Level (-9.3084)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (9.5053)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
Stock Forecast FAQ
In the current month, DCTH has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The DCTH average analyst price target in the past 3 months is --.
-
Where Will Delcath Systems Stock Be In 1 Year?
According to analysts, the consensus estimate is that Delcath Systems share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Delcath Systems?
Analysts are divided on their view about Delcath Systems share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Delcath Systems is a Sell and believe this share price will drop from its current level to --.
-
What Is Delcath Systems's Price Target?
The price target for Delcath Systems over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is DCTH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Delcath Systems is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of DCTH?
You can purchase shares of Delcath Systems via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Delcath Systems shares.
-
What Is The Delcath Systems Share Price Today?
Delcath Systems was last trading at $11.36 per share. This represents the most recent stock quote for Delcath Systems. Yesterday, Delcath Systems closed at $11.34 per share.
-
How To Buy Delcath Systems Stock Online?
In order to purchase Delcath Systems stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
